## Gene Summary
MAML3, or Mastermind Like Transcriptional Coactivator 3, is a member of the Mastermind-like family of proteins, which are critical components in the Notch signaling pathway. This gene reproduces a transcriptional coactivator for Notch receptors, which are involved in the regulation of cell fate decisions. MAML3 is ubiquitously expressed with higher expression levels observed in certain tissues such as the brain. This gene encodes a protein that is known to form a complex with both DNA-bound Notch receptors and the transcription factor CBF1/Su(H)/Lag-1 to activate transcription from Notch target genes.

## Gene Drugs, Diseases, Phenotypes, and Pathways
MAML3 is significantly implicated in the Notch signaling pathway, influencing cell proliferation, differentiation, and apoptosis. The disruption or dysregulation of MAML3 function is linked to several developmental disorders and cancers. Particularly, alterations in MAML3 have been associated with various cancer types including those of the lung and colon. This is primarily due to its role in regulating transcriptional outcomes that affect cell cycle and growth pathways. As a component of the Notch pathway, MAML3 contributes indirectly to the regulation of genes that are crucial for the development and progression of these diseases.

## Pharmacogenetics
The pharmacogenetics of MAML3 are not as well defined as with some other genes, largely because direct targeting of MAML3 in a pharmacological context is still under research. However, given its role in the Notch signaling pathway, drugs that modulate this pathway could theoretically influence the activity of MAML3. For example, gamma-secretase inhibitors, used experimentally in treating Alzheimer's disease and cancers, could indirectly affect MAML3 function by reducing the production of Notch intracellular domain (NICD), thus decreasing MAML3-mediated transcriptional activation. Nonetheless, specific drug interactions directly involving MAML3 and exact pharmacogenetic profiles need further detailed investigation to establish precise clinical implications and effectiveness based on individual genetic makeup.